Oaktree Acquisition III Life Sciences EPS - Earnings per Share 2025-2024 | OACC

Oaktree Acquisition III Life Sciences eps - earnings per share from 2025 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Oaktree Acquisition III Life Sciences Annual EPS
Oaktree Acquisition III Life Sciences Quarterly EPS
2024-09-30 $0.00
Sector Industry Market Cap Revenue
$0.235B $0.000B
Oaktree Acquisition Corp. III Life Sciences is a blank check company. It formed for the purpose of entering into a combination with one or more businesses or entities. Oaktree Acquisition Corp. III is based in LOS ANGELES.
Stock Name Country Market Cap PE Ratio
Flowco Holdings (FLOC) United States $1.736B 0.00
Aduro Clean Technologies (ADUR) Canada $0.201B 0.00
Range Capital Acquisition (RANG) United States $0.142B 0.00
Tavia Acquisition (TAVI) $0.141B 0.00
YSX Tech (YSXT) China $0.104B 0.00
CO2 Energy Transition (NOEM) United States $0.096B 0.00
Leishen Energy Holding (LSE) China $0.088B 0.00
YHN Acquisition I (YHNA) $0.082B 0.00
Uni-Fuels Holdings (UFG) $0.051B 0.00
Youxin Technology (YAAS) China $0.041B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.025B 0.00
Sky Quarry (SKYQ) United States $0.017B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.014B 0.00
PicoCELA (PCLA) Japan $0.010B 0.00